In a recent regulatory filing, Thermo disclosed that it acquired Core Informatics for $94 million and Finesse Solutions for $220 million.
The embattled firm has reached deals with both the Centers for Medicare & Medicaid Services and Arizona.
Illumina follows Agilent, Life Technologies, Affymetrix, Siemens, and Luminex in settling lawsuits alleging infringement of US Patent No 7,064,197.
Thermo Fisher Scientific subsidiary Life Technologies will pay Enzo $35 million for infringing on two patents pertaining to labeled nucleotides and nucleic acids.
Affymetrix will pay Enzo $10 million to settle litigation Enzo brought against the company over a method for nucleic acid analysis.
Luminex will pay Enzo Biochem $7.1 million to settle a lawsuit alleging infringement of patents for oligonucleotides and solid supports for fixed nucleic acids.
The deal comes after a California Superior Court found no fraudulent intent on the part of the company.
The companies had been involved in a years-long legal battle over whether Genmark's eSensor Respiratory Virus Panel infringed ViroNovative's human metapneumovirus IP.
The preliminary approval is the penultimate step to bringing to a close a class action lawsuit accusing Celera of making false and misleading statements about its finances.
A few more lawsuits related to Myriad Genetics' hereditary cancer testing patents are now put to bed.
CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.
Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.
Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.
In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.